Cargando…

Systemic vascular function, measured with forearm flow mediated dilatation, in acute and stable cerebrovascular disease: a case-control study

BACKGROUND: Acute ischaemic stroke is associated with alteration in systemic markers of vascular function. We measured forearm vascular function (using forearm flow mediated dilatation) to clarify whether recent acute ischaemic stroke/TIA is associated with impaired systemic vascular function. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Beer, Christopher D, Potter, Kathleen, Blacker, David, Arnolda, Leonard, Hankey, Graeme J, Puddey, Ian B
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970588/
https://www.ncbi.nlm.nih.gov/pubmed/20955612
http://dx.doi.org/10.1186/1476-7120-8-46
_version_ 1782190475106582528
author Beer, Christopher D
Potter, Kathleen
Blacker, David
Arnolda, Leonard
Hankey, Graeme J
Puddey, Ian B
author_facet Beer, Christopher D
Potter, Kathleen
Blacker, David
Arnolda, Leonard
Hankey, Graeme J
Puddey, Ian B
author_sort Beer, Christopher D
collection PubMed
description BACKGROUND: Acute ischaemic stroke is associated with alteration in systemic markers of vascular function. We measured forearm vascular function (using forearm flow mediated dilatation) to clarify whether recent acute ischaemic stroke/TIA is associated with impaired systemic vascular function. METHODS: Prospective case control study enrolling 17 patients with recent acute ischaemic stroke/TIA and 17 sex matched controls with stroke more than two years previously. Forearm vascular function was measured using flow medicated dilatation (FMD). RESULTS: Flow mediated dilatation was 6.0 ± 1.1% in acute stroke/TIA patients and 4.7 ± 1.0% among control subjects (p = 0.18). The mean paired difference in FMD between subjects with recent acute stroke and controls was 1.25% (95% CI -0.65, 3.14; p = 0.18). Endothelium independent dilatation was measured in six pairs of participants and was similar in acute stroke/TIA patients (22.6 ± 4.3%) and control subjects (19.1 ± 2.6%; p = 0.43). CONCLUSIONS: Despite the small size of this study, these data indicate that recent acute stroke is not necessarily associated with a clinically important reduction in FMD.
format Text
id pubmed-2970588
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29705882010-11-03 Systemic vascular function, measured with forearm flow mediated dilatation, in acute and stable cerebrovascular disease: a case-control study Beer, Christopher D Potter, Kathleen Blacker, David Arnolda, Leonard Hankey, Graeme J Puddey, Ian B Cardiovasc Ultrasound Research BACKGROUND: Acute ischaemic stroke is associated with alteration in systemic markers of vascular function. We measured forearm vascular function (using forearm flow mediated dilatation) to clarify whether recent acute ischaemic stroke/TIA is associated with impaired systemic vascular function. METHODS: Prospective case control study enrolling 17 patients with recent acute ischaemic stroke/TIA and 17 sex matched controls with stroke more than two years previously. Forearm vascular function was measured using flow medicated dilatation (FMD). RESULTS: Flow mediated dilatation was 6.0 ± 1.1% in acute stroke/TIA patients and 4.7 ± 1.0% among control subjects (p = 0.18). The mean paired difference in FMD between subjects with recent acute stroke and controls was 1.25% (95% CI -0.65, 3.14; p = 0.18). Endothelium independent dilatation was measured in six pairs of participants and was similar in acute stroke/TIA patients (22.6 ± 4.3%) and control subjects (19.1 ± 2.6%; p = 0.43). CONCLUSIONS: Despite the small size of this study, these data indicate that recent acute stroke is not necessarily associated with a clinically important reduction in FMD. BioMed Central 2010-10-19 /pmc/articles/PMC2970588/ /pubmed/20955612 http://dx.doi.org/10.1186/1476-7120-8-46 Text en Copyright ©2010 Beer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Beer, Christopher D
Potter, Kathleen
Blacker, David
Arnolda, Leonard
Hankey, Graeme J
Puddey, Ian B
Systemic vascular function, measured with forearm flow mediated dilatation, in acute and stable cerebrovascular disease: a case-control study
title Systemic vascular function, measured with forearm flow mediated dilatation, in acute and stable cerebrovascular disease: a case-control study
title_full Systemic vascular function, measured with forearm flow mediated dilatation, in acute and stable cerebrovascular disease: a case-control study
title_fullStr Systemic vascular function, measured with forearm flow mediated dilatation, in acute and stable cerebrovascular disease: a case-control study
title_full_unstemmed Systemic vascular function, measured with forearm flow mediated dilatation, in acute and stable cerebrovascular disease: a case-control study
title_short Systemic vascular function, measured with forearm flow mediated dilatation, in acute and stable cerebrovascular disease: a case-control study
title_sort systemic vascular function, measured with forearm flow mediated dilatation, in acute and stable cerebrovascular disease: a case-control study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970588/
https://www.ncbi.nlm.nih.gov/pubmed/20955612
http://dx.doi.org/10.1186/1476-7120-8-46
work_keys_str_mv AT beerchristopherd systemicvascularfunctionmeasuredwithforearmflowmediateddilatationinacuteandstablecerebrovasculardiseaseacasecontrolstudy
AT potterkathleen systemicvascularfunctionmeasuredwithforearmflowmediateddilatationinacuteandstablecerebrovasculardiseaseacasecontrolstudy
AT blackerdavid systemicvascularfunctionmeasuredwithforearmflowmediateddilatationinacuteandstablecerebrovasculardiseaseacasecontrolstudy
AT arnoldaleonard systemicvascularfunctionmeasuredwithforearmflowmediateddilatationinacuteandstablecerebrovasculardiseaseacasecontrolstudy
AT hankeygraemej systemicvascularfunctionmeasuredwithforearmflowmediateddilatationinacuteandstablecerebrovasculardiseaseacasecontrolstudy
AT puddeyianb systemicvascularfunctionmeasuredwithforearmflowmediateddilatationinacuteandstablecerebrovasculardiseaseacasecontrolstudy